It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Synchron Switch is implanted through the blood vessels to allow people with no or very limited physical mobility to operate technology such as cursors and smart home devices using their mind. So far, the nascent technology has been used on three patients in the U.S. and four in Australia.
Synchron's BCI is inserted through the blood vessels, which Oxley calls the "natural highways" into the brain. Synchron's stent, called the Stentrode, is fitted with tiny sensors and is delivered to the large vein that sits next to the motor cortex. The Stentrode is connected to an antenna that sits under the skin in the chest and collects raw brain data that it sends out of the body to external devices.
In January, Synchron announced a 12-month long-term safety data from the first-in-human trial. The company enrolled four patients with severe paralysis in Australia. Participants were implanted with Synchron’s first-generation neuroprosthesis device.
The data analysis showed that the neuroprosthesis device can transmit neural signals over a long period without any serious adverse events related to the device. The signal quality remained stable, and no evidence of significant deterioration was reported.
The trial participants were able to successfully control a personal computing device with the BCI and use the implant to generate digital switches under intentional control for daily digital activities.
Earlier this year, the FDA approved another BCI clinical trial in humans. Neuralink, which was founded by business magnate Elon Musk, is ready to investigate its implantable BIC chip in humans to help treat a range of conditions.
originally posted by: aliensanonymous
a reply to: quintessentone
Sounds promising for people afflicted with CNS disorders or suffering from a severe accident.